Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1S10OD028504-01
An AVANCE NEO 400 MHz NMR Spectrometer for Chemical Biology and Drug Discovery
National Institutes of Health
Grant: 5R35GM124838-04
Chemical and structural tools to study energy homeostasis pathways in cancer and diabetes
National Institutes of Health
Grant: 3P41GM111244-03S1
Life Science and Biomedical technology Research center at NSLS-II LSBR
National Institutes of Health
Grant: 1R21HD102745-01A1
Substrate reduction as a novel therapeutic strategy for Glutaric Aciduria Type 1
National Institutes of Health
Grant: 1S10OD025132-01A1
An AVANCE NEO 600 MHz NMR Spectrometer System for Structural and Chemical Biology
Fields of Study
Keywords
Sustainable Development Goals